When a Blood Donor Has Sickle Cell Trait: Incidental Findings and Public Health

There are no national recommendations for routine screening for sickle cell trait, nor is there guidance on whether or how to notify donors that they might be tested or identified as having sickle cell trait. As a result, the organizations that collect blood have implemented variable policies about...

Ausführliche Beschreibung

Gespeichert in:  
Bibliographische Detailangaben
VerfasserInnen: Lee, Lisa M. (Verfasst von) ; Marks, Peter (Verfasst von)
Medienart: Elektronisch Aufsatz
Sprache:Englisch
Verfügbarkeit prüfen: HBZ Gateway
Fernleihe:Fernleihe für die Fachinformationsdienste
Veröffentlicht: 2014
In: The Hastings Center report
Jahr: 2014, Band: 44, Heft: 4, Seiten: 17-21
Online-Zugang: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002c 4500
001 1937534057
003 DE-627
005 20251002055623.0
007 cr uuu---uuuuu
008 251002s2014 xx |||||o 00| ||eng c
024 7 |a 10.1002/hast.327  |2 doi 
035 |a (DE-627)1937534057 
035 |a (DE-599)KXP1937534057 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Lee, Lisa M.  |e VerfasserIn  |4 aut 
245 1 0 |a When a Blood Donor Has Sickle Cell Trait: Incidental Findings and Public Health 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a There are no national recommendations for routine screening for sickle cell trait, nor is there guidance on whether or how to notify donors that they might be tested or identified as having sickle cell trait. As a result, the organizations that collect blood have implemented variable policies about whether and how to inform prospective donors of the possible screening and discovery of this noncommunicable condition. The question of what they should do is related to the broader question of how to handle incidental and secondary findings. In a recent report, the Presidential Commission for the Study of Bioethical Issues outline a framework for handling such findings in the clinical, research, and direct-to-consumer contexts. While the commission's report did not directly address incidental and secondary findings in the public health context of blood donation, it made several overarching recommendations that apply in all contexts where such findings might arise. This essay outlines the special issues raised by discovering sickle cell trait in blood donation and considers the implications of the commission's framework for that problem. 
601 |a Public Health 
700 1 |a Marks, Peter  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |a Hastings Center  |t The Hastings Center report  |d Malden, Mass. : Wiley, 1971  |g 44(2014), 4, Seite 17-21  |h Online-Ressource  |w (DE-627)341346551  |w (DE-600)2067369-3  |w (DE-576)258761822  |x 1552-146X  |7 nnas 
773 1 8 |g volume:44  |g year:2014  |g number:4  |g pages:17-21 
856 4 0 |u https://doi.org/10.1002/hast.327  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/hast.327  |x Verlag  |z lizenzpflichtig  |3 Volltext 
912 |a NOMM 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4779660238 
LOK |0 003 DE-627 
LOK |0 004 1937534057 
LOK |0 005 20251002055623 
LOK |0 008 251002||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2025-09-26#78935D4C2EA055A814EA79B148FBD174FBF02DF2 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixrk  |a ixzs  |a zota  |a tiep 
ORI |a TA-MARC-ixtheoa001.raw